Suscribirse

Pilot Randomized Controlled Trial to Reduce Readmission for Heart Failure Using Novel Tablet and Nurse Practitioner Education - 16/08/18

Doi : 10.1016/j.amjmed.2018.02.017 
Khadijah Breathett, MD, MS a, * , Scott Maffett, MD b, Randi E. Foraker, PhD c, Rod Sturdivant, PhD d, Kristina Moon, DO e, Ayesha Hasan, MD b, Veronica Franco, MD b, Sakima Smith, MD, MPH b, Brent C. Lampert, DO b, Sitaramesh Emani, MD b, Garrie Haas, MD b, Rami Kahwash, MD b, Ray E. Hershberger, MD b, Philip F. Binkley, MD, MPH b, Laura Helmkamp, MS f, Kathryn Colborn, PhD f, Pamela N. Peterson, MD, MSPH g, Nancy Sweitzer, MD, PhD a, William T. Abraham, MD b
a Division of Cardiovascular Medicine, Sarver Heart Center, University of Arizona, Tucson 
b Division of Cardiovascular Medicine, Ohio State University Wexner Medical Center, Columbus 
c Institute for Informatics, Washington University in St. Louis School of Medicine, Mo 
d Department of Mathematics and Physics, Azusa Pacific University, Calif 
e Division of Cardiology, University of Wisconsin, Madison 
f University of Colorado Adult and Child Consortium for Health Outcomes Research and Delivery Science, Aurora 
g Division of Cardiology, University of Colorado and Denver Health Medical Center, Denver 

*Requests for reprints should be addressed to Khadijah Breathett, MD, MS, Division of Cardiovascular Medicine, Sarver Heart Center, University of Arizona, 1501 N. Campbell Avenue, P.O. Box 245046, Tucson, AZ 85724.Division of Cardiovascular MedicineSarver Heart CenterUniversity of Arizona1501 N. Campbell Avenue, P.O. Box 245046TucsonAZ85724

Abstract

Background

Heart failure education programs are not standardized. The best form of education is unclear. We evaluated whether addition of a novel tablet application to nurse practitioner (NP) education was superior to NP education alone in reducing 30-day readmission after heart failure hospitalization.

Methods

From February 2015-March 2016, patients admitted to a quaternary academic center with primary diagnosis of heart failure were randomized to 1) treatment – NP education plus tablet application (interactive conditional logic program that flags patient questions to medical staff), or 2) control – NP education. The primary outcome was reduction in 30-day readmission rate. Secondary outcomes included satisfaction and education assessed via survey.

Results

Randomization included 60 patients to treatment and 66 to control. A total of 13 patients withdrew prior to intervention (treatment n = 4, control n = 1) or were lost to follow-up (treatment n = 3, control n = 5). The 30-day readmission rate trended lower for treatment compared with control, but results were not statistically significant (13.2% [7/53], 26.7% [16/60], respectively, P = .08). Similarly, satisfaction trended higher with treatment than control (P = .08). Treatment patients rated explanations from their physicians higher than control (Always: 83.7%, 55.8%, respectively, P = .01).

Conclusions

NP education plus tablet use was not associated with significantly lower 30-day readmission rates in comparison with NP alone, but a positive trend was seen. Patient satisfaction trended higher and heart failure explanations were better with NP education plus tablet. A larger study is needed to determine if NP education plus tablet reduces readmission rates following heart failure admission.

El texto completo de este artículo está disponible en PDF.

Keywords : Educational technology, Heart failure, Nurse practitioner, Patient education, Readmission


Esquema


 Funding: KB received support from the Ohio State University Department of Medicine seed grant award; National Institutes of Health (NIH) L60 MD010857; the University of Colorado, Department of Medicine, Health Services Research Development Grant Award; and the University of Arizona Health Sciences, Strategic Priorities Faculty Initiative Grant. EngineeredCare provided loaner tablets for this study. Tablet applications were developed by EngineeredCare and KB.
 Conflicts of Interest: KB has no ownership in EngineeredCare. No employees of EngineeredCare were included with analysis nor development of this manuscript. Otherwise there are no disclosures.
 Authorship: All authors had access to data and a role in writing this manuscript.


© 2018  Elsevier Inc. Reservados todos los derechos.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 131 - N° 8

P. 974-978 - août 2018 Regresar al número
Artículo precedente Artículo precedente
  • The Reply
  • Larry A. Weinrauch, John A. D'Elia, Matthew R. Weir, Suphamai Bunnapradist, Peter V. Finn, Jiankang Liu, Brian Claggett, Anthony P. Monaco
| Artículo siguiente Artículo siguiente
  • Adopting the Quadruple Aim: The University of Rochester Medical Center Experience : Moving from Physician Burnout to Physician Resilience
  • Allen P. Anandarajah, Timothy E. Quill, Michael R. Privitera

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

@@150455@@ Voir plus

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2026 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.